VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own ...

At 43, Shira Boehler was everything the modern health narrative celebrates: disciplined, active, a 6-mile runner, and ...

Improvements in some domains of cognitive function seen for patients with cancer receiving chemotherapy reporting cognitive problems.

While the U.S. breast cancer death rate declined by 43% between 1990 and 2025 following the proliferation of mammograms, per ...